Mylan

  • Dymista 2017 report

    Dymista 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Elestrin 2017 report

    Elestrin 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 17 Pages The 5 Key Questions Addressed by this Report:...

  • Epinephrine 2017 report

    Epinephrine 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • EpiPen 2017 report

    EpiPen 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Fentanyl Patch 2017 report

    Fentanyl Patch 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this...

  • Olux 2017 report

    Olux 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 17 Pages The 5 Key Questions Addressed by this Report:...

  • Perforomist 2017 report

    Perforomist 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Silenor 2017 report

    Silenor 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Ultiva 2017 report

    Ultiva 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 17 Pages The 5 Key Questions Addressed by this Report:...

  • Xulane 2017 report

    Xulane 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 17 Pages The 5 Key Questions Addressed by this Report:...

  • Denavir 2016 report

    Denavir 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 15 Pages The 5 Key Questions Addressed by this Report:...

  • EpiPen 2016 report

    EpiPen 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 28 Pages The 5 Key Questions Addressed by this Report:...